453
Views
57
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE: CELLULAR AND MOLECULAR BIOLOGY

Peroxiredoxin 6 Overexpression Attenuates Cisplatin-Induced Apoptosis in Human Ovarian Cancer Cells

, , , , , , & show all
Pages 21-28 | Published online: 17 Dec 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Ju-Won Roh, Jung Eun Choi, Hee Dong Han, Wei Hu, Koji Matsuo, Masato Nishimura, Ju-Seog Lee, Sun Young Kwon, Chi Heum Cho, Jongseung Kim, Robert L. Coleman, Gabriel Lopez-Bernstein & Anil K. Sood. (2020) Clinical and biological significance of EZH2 expression in endometrial cancer. Cancer Biology & Therapy 21:2, pages 147-156.
Read now
Jun Xu, Qiang Su, Mingxia Gao, Qingsong Liang, Junfeng Li & Xu Chen. (2019) Differential Expression And Effects Of Peroxiredoxin-6 On Drug Resistance And Cancer Stem Cell-Like Properties In Non-Small Cell Lung Cancer. OncoTargets and Therapy 12, pages 10477-10486.
Read now
Ming-Jun Zheng, Jing Wang, Hui-Min Wang, Ling-Ling Gao, Xiao Li, Wen-Chao Zhang, Rui Gou, Qian Guo, Xin Nie, Juan-Juan Liu & Bei Lin. (2018) Decreased expression of peroxiredoxin1 inhibits proliferation, invasion, and metastasis of ovarian cancer cell. OncoTargets and Therapy 11, pages 7745-7761.
Read now
I. K. Kim, K. J. Lee, S. Rhee, S. B. Seo & J. H. Pak. (2013) Protective effects of Peroxiredoxin 6 overexpression on amyloid β-induced apoptosis in PC12 cells. Free Radical Research 47:10, pages 836-846.
Read now
Wang Zhiyu, Cheng Yue, Wang Neng, Wang Dong Mei, Li Ying Wei, Han Feng, Shen Jian Gang, Yang De Po, Guan Xin Yuan & Chen Jian-Ping. (2012) Dioscin induces cancer cell apoptosis through elevated oxidative stress mediated by downregulation of peroxiredoxins. Cancer Biology & Therapy 13:3, pages 138-147.
Read now

Articles from other publishers (52)

Jianyi Zhang, Chunhua Li, Kai Ren, Min Hong, Jiayue Cui & Jiankai Liu. (2023) Cytotoxicity of alkaline serine protease (ASPNJ) on Jurkat cells and its correlation with changes in the expression of membrane‐associated proteins. Journal of Biochemical and Molecular Toxicology 37:11.
Crossref
Yan Liu, Pu Wang, Weina Hu & Da Chen. (2023) New insights into the roles of peroxiredoxins in cancer. Biomedicine & Pharmacotherapy 164, pages 114896.
Crossref
Daniel J. Lagal, María J. López-Grueso, José R. Pedrajas, Thomas L. Leto, J. Antonio Bárcena, Raquel Requejo-Aguilar & C. Alicia Padilla. (2023) Loss of PRDX6 Aborts Proliferative and Migratory Signaling in Hepatocarcinoma Cell Lines. Antioxidants 12:6, pages 1153.
Crossref
Wenhui Jia, Chunling Dong & Bo Li. (2023) Anti-Oxidant and Pro-Oxidant Effects of Peroxiredoxin 6: A Potential Target in Respiratory Diseases. Cells 12:1, pages 181.
Crossref
Marina M. Tavleeva, Elena S. Belykh, Anna V. Rybak, Elena E. Rasova, Aleksey A. Chernykh, Zaur B. Ismailov & Ilya O. Velegzhaninov. (2022) Effects of Antioxidant Gene Overexpression on Stress Resistance and Malignization In Vitro and In Vivo: A Review. Antioxidants 11:12, pages 2316.
Crossref
Barbora Salovska, Alexandra Kondelova, Kristyna Pimkova, Zuzana Liblova, Miroslav Pribyl, Ivo Fabrik, Jiri Bartek, Marie Vajrychova & Zdenek Hodny. (2022) Peroxiredoxin 6 protects irradiated cells from oxidative stress and shapes their senescence-associated cytokine landscape. Redox Biology 49, pages 102212.
Crossref
Unbin Chae, Bokyung Kim, HanSeop Kim, Young-Ho Park, Seung Hwan Lee, Sun-Uk Kim & Dong-Seok Lee. (2021) Peroxiredoxin-6 regulates p38-mediated epithelial–mesenchymal transition in HCT116 colon cancer cells. Journal of Biological Research-Thessaloniki 28:1.
Crossref
Lei Gao, Jialin Meng, Chuang Yue, Xingyu Wu, Quanxin Su, Hao Wu, Ze Zhang, Qinzhou Yu, Shenglin Gao, Song Fan & Li Zuo. (2021) Integrative analysis the characterization of peroxiredoxins in pan-cancer. Cancer Cell International 21:1.
Crossref
Chen Chen, Lijie Gong, Xiaoqin Liu, Tianyu Zhu, Wuxi Zhou, Lingyi Kong & Jianguang Luo. (2021) Identification of peroxiredoxin 6 as a direct target of withangulatin A by quantitative chemical proteomics in non-small cell lung cancer. Redox Biology 46, pages 102130.
Crossref
Daciele Paola Preci, Angélica Almeida, Anne Liss Weiler, Maria Luiza Mukai Franciosi & Andréia Machado Cardoso. (2021) Oxidative damage and antioxidants in cervical cancer. International Journal of Gynecologic Cancer 31:2, pages 265-271.
Crossref
María José Grueso, Rosa María Valero, Hidalgo B. Carmona, Dniel José Ruiz, José Peinado, Brian McDonagh, Raquel Aguilar, José Antonio Ruiz & Carmen Alicia Peña. (2019) Peroxiredoxin 6 Down-Regulation Induces Metabolic Remodeling and Cell Cycle Arrest in HepG2 Cells. Antioxidants 8:11, pages 505.
Crossref
Jie Mei, Leiyu Hao, Xiaorui Liu, Guangshun Sun, Rui Xu, Huiyu Wang & Chaoying Liu. (2019) Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer. Biomarker Research 7:1.
Crossref
M. G. Sharapov & V. I. Novoselov. (2019) Catalytic and Signaling Role of Peroxiredoxins in Carcinogenesis. Biochemistry (Moscow) 84:2, pages 79-100.
Crossref
Francesca PacificiDavid Della MorteBarbara CapuaniDonatella PastoreAlfonso BelliaPaolo SbracciaNicola Di DanieleRenato LauroDavide Lauro. (2019) Peroxiredoxin6, a Multitask Antioxidant Enzyme Involved in the Pathophysiology of Chronic Noncommunicable Diseases. Antioxidants & Redox Signaling 30:3, pages 399-414.
Crossref
Mars G. Sharapov, Vladimir I. Novoselov & Sergey V. Gudkov. (2019) Radioprotective Role of Peroxiredoxin 6. Antioxidants 8:1, pages 15.
Crossref
Saisai Li, Xiaoli Hu, Miaomiao Ye & Xueqiong Zhu. (2018) The prognostic values of the peroxiredoxins family in ovarian cancer. Bioscience Reports 38:5.
Crossref
Mark B. HamptonKate A. VickJohn J. SkokoCarola A. Neumann. (2018) Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer. Antioxidants & Redox Signaling 28:7, pages 591-608.
Crossref
Arun K. B., Aravind Madhavan, Reshmitha T. R.Sithara ThomasP. Nisha. (2018) Musa paradisiaca inflorescence induces human colon cancer cell death by modulating cascades of transcriptional events . Food & Function 9:1, pages 511-524.
Crossref
Guo‐Yan Liu, Jing‐Xian Shi, Song‐Lin Shi, Fan Liu, Gang Rui, Xiao Li, Li‐Bin Gao, Xiao‐Ling Deng & Qi‐Fu Li. (2017) Nucleophosmin Regulates Intracellular Oxidative Stress Homeostasis via Antioxidant PRDX6. Journal of Cellular Biochemistry 118:12, pages 4697-4707.
Crossref
Jun Xu, Shouru Zhang, Rong Wang, Xingye Wu, Li Zeng & Zhongxue Fu. (2017) Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway. Bioscience Reports 37:3.
Crossref
Kwang Il Park, Hyeonsoo Park, Arulkumar Nagappan, Gyeong Eun Hong, Silvia Yumnam, Ho Jeong Lee, Eun Hee Kim, Won Sup Lee, Sung Chul Shin, Jin A Kim, Sang Joon Lee, Jin Yeul Ma, Taesun Min, Jeong Doo Heo & Gon Sup Kim. (2017) Polyphenolic compounds from Korean Lonicera japonica Thunb. induces apoptosis via AKT and caspase cascade activation in A549 cells. Oncology Letters 13:4, pages 2521-2530.
Crossref
Arianna Nicolussi, Sonia D'Inzeo, Carlo Capalbo, Giuseppe Giannini & Anna Coppa. (2017) The role of peroxiredoxins in cancer. Molecular and Clinical Oncology 6:2, pages 139-153.
Crossref
Jhang Ho Pak, Woo Chan Son, Sang-Beom Seo, Sung-Jong Hong, Woon-Mok Sohn, Byoung-Kuk Na & Tong-Soo Kim. (2016) Peroxiredoxin 6 expression is inversely correlated with nuclear factor-κB activation during Clonorchis sinensis infestation. Free Radical Biology and Medicine 99, pages 273-285.
Crossref
Mi Hee Park, MiRan Jo, Yu Ri Kim, Chong-Kil Lee & Jin Tae Hong. (2016) Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases. Pharmacology & Therapeutics 163, pages 1-23.
Crossref
Shihao Li, Fuhua Li, Zheng Sun, Xiaojun Zhang & Jianhai Xiang. (2016) Differentially proteomic analysis of the Chinese shrimp at WSSV latent and acute infection stages by iTRAQ approach. Fish & Shellfish Immunology 54, pages 629-638.
Crossref
Julie Bensimon, Denis Biard, Vincent Paget, Maud Goislard, Sandrine Morel-Altmeyer, Julie Konge, Sylvie Chevillard & Jérôme Lebeau. (2016) Forced extinction of CD24 stem-like breast cancer marker alone promotes radiation resistance through the control of oxidative stress. Molecular Carcinogenesis 55:3, pages 245-254.
Crossref
Ayodeji A. Asuni, Maitea Guridi, Sandrine Sanchez & Martin J. Sadowski. (2015) Antioxidant peroxiredoxin 6 protein rescues toxicity due to oxidative stress and cellular hypoxia in?vitro, and attenuates prion-related pathology in?vivo. Neurochemistry International 90, pages 152-165.
Crossref
Hye Lim Lee, Mi Hee Park, Dong Ju Son, Ho Sueb Song, Jung Hyun Kim, Seong Cheol Ko, Min Jong Song, Won Hyoung Lee, Joo Hee Yoon, Young Wan Ham, Sang Bae Han & Jin Tae Hong. (2015) Anti-cancer effect of snake venom toxin through down regulation of AP-1 mediated PRDX6 expression. Oncotarget 6:26, pages 22139-22151.
Crossref
Milla Elvi Linnea Kuusisto, Kirsi-Maria Haapasaari, Taina Turpeenniemi-Hujanen, Esa Jantunen, Ylermi Soini, Pekka Peroja, Risto Bloigu, Peeter Karihtala & Outi Kuittinen. (2015) High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of International Prognostic Index. Journal of Clinical Pathology 68:7, pages 552-556.
Crossref
Hyung-Mun Yun, Kyung-Ran Park, Mi Hee Park, Dae Hwan Kim, Mi Ran Jo, Ji Young Kim, Eun-Cheol Kim, Do Young Yoon, Sang Bae Han & Jin Tae Hong. (2015) PRDX6 promotes tumor development via the JAK2/STAT3 pathway in a urethane-induced lung tumor model. Free Radical Biology and Medicine 80, pages 136-144.
Crossref
Chih-Chang Hung, Chen-Yu Chien, Wei-Fan Chiang, Chang-Shen Lin, Tzyh-Chyuan Hour, Hau-Ren Chen, Ling-Feng Wang, Jenq-Yuh Ko, Chi-Hua Chang & Jeff Yi-Fu Chen. (2015) p22phox confers resistance to cisplatin, by blocking its entry into the nucleus. Oncotarget 6:6, pages 4110-4125.
Crossref
Lixu Jin, Yi Huo, Zhiguo Zheng, Xiaoyong Jiang, Haiyun Deng, Yuling Chen, Qingquan Lian, Renshan Ge & Haiteng Deng. (2014) Down-regulation of Ras-related Protein Rab 5C-dependent Endocytosis and Glycolysis in Cisplatin-resistant Ovarian Cancer Cell Lines. Molecular & Cellular Proteomics 13:11, pages 3138-3151.
Crossref
Mark R. Kelley, Yanlin Jiang, Chunlu Guo, April Reed, Hongdi Meng & Michael R. Vasko. (2014) Role of the DNA Base Excision Repair Protein, APE1 in Cisplatin, Oxaliplatin, or Carboplatin Induced Sensory Neuropathy. PLoS ONE 9:9, pages e106485.
Crossref
Hyung-Mun Yun, Kyung-Ran Park, Hee Peum Lee, Dong Hun Lee, Miran Jo, Dea Hwan Shin, Do-Young Yoon, Sang Bae Han & Jin Tae Hong. (2014) PRDX6 promotes lung tumor progression via its GPx and iPLA2 activities. Free Radical Biology and Medicine 69, pages 367-376.
Crossref
Ga Park, Daejin Kim, Hoi Yoon, Yeong-Seok Kim, Hyun-Kyung Lee, Ki Kim, Dae Jeong & Dae Hur. (2014) Antibody ligation of CM1 on cisplatin-exposed HeLa cells induces apoptosis through reactive oxygen species-dependent Fas ligand expression. International Journal of Oncology.
Crossref
Miran Jo, Hyung-Mun Yun, Kyung-Ran Park, Mi Hee Park, Dong Hun Lee, Seung Hee Cho, Hwan-Soo Yoo, Yong-Moon Lee, Heon Sang Jeong, Youngsoo Kim, Jae Kyung Jung, Bang Yeon Hwang, Mi Kyeong Lee, Nam Doo Kim, Sang Bae Han & Jin Tae Hong. (2014) Anti-Cancer Effect of Thiacremonone through Down Regulation of Peroxiredoxin 6. PLoS ONE 9:3, pages e91508.
Crossref
Ahmed Ouali, Mohammed Gagaoua, Yasmine Boudida, Samira Becila, Abdelghani Boudjellal, Carlos H. Herrera-Mendez & Miguel A. Sentandreu. (2013) Biomarkers of meat tenderness: Present knowledge and perspectives in regards to our current understanding of the mechanisms involved. Meat Science 95:4, pages 854-870.
Crossref
Shuangwei Zou, Qi Shen, Ying Hua, Wenxiao Jiang, Wenwen Zhang & Xueqiong Zhu. (2013) Proteomic Identification of Neoadjuvant Chemotherapy-Related Proteins in Bulky Stage IB-IIA Squamous Cervical Cancer. Reproductive Sciences 20:11, pages 1356-1364.
Crossref
Eva-Maria HanschmannJosé Rodrigo GodoyCarsten BerndtChristoph HudemannChristopher Horst Lillig. (2013) Thioredoxins, Glutaredoxins, and Peroxiredoxins—Molecular Mechanisms and Health Significance: from Cofactors to Antioxidants to Redox Signaling. Antioxidants & Redox Signaling 19:13, pages 1539-1605.
Crossref
H C Whitaker, D Patel, W J Howat, A Y Warren, J D Kay, T Sangan, J C Marioni, J Mitchell, S Aldridge, H J Luxton, C Massie, A G Lynch & D E Neal. (2013) Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress. British Journal of Cancer 109:4, pages 983-993.
Crossref
Xin-yan Wang, Hai-jiao Wang & Xiu-qin Li. (2013) Peroxiredoxin III protein expression is associated with platinum resistance in epithelial ovarian cancer. Tumor Biology 34:4, pages 2275-2281.
Crossref
K. Brasseur, V. Leblanc, F. Fabi, S. Parent, C. Descôteaux, G. Bérubé & E. Asselin. (2013) ERα-Targeted Therapy in Ovarian Cancer Cells by a Novel Estradiol-Platinum(II) Hybrid. Endocrinology 154:7, pages 2281-2295.
Crossref
Frank Rolfs, Marcel Huber, Florian Gruber, Friederike Böhm, Herbert J. Pfister, Valery N. Bochkov, Erwin Tschachler, Reinhard Dummer, Daniel Hohl, Matthias Schäfer & Sabine Werner. (2013) Dual Role of the Antioxidant Enzyme Peroxiredoxin 6 in Skin Carcinogenesis. Cancer Research 73:11, pages 3460-3469.
Crossref
Bhavana ChhunchhaNigar FatmaEri Kubo, Prerana RaiSanjay P. Singh & Dhirendra P. Singh. (2013) Curcumin abates hypoxia-induced oxidative stress based-ER stress-mediated cell death in mouse hippocampal cells (HT22) by controlling Prdx6 and NF-κB regulation. American Journal of Physiology-Cell Physiology 304:7, pages C636-C655.
Crossref
Jie Duan. (2013) siRNA targeting of PRDX3 enhances cisplatin‑induced apoptosis in ovarian cancer cells through the suppression of the NF‑κB signaling pathway. Molecular Medicine Reports.
Crossref
Yong‐Yang Zhu, Guangchuang Yu, Ye Zhang, Zheng Xu, Yu‐Qiang Wang, Guang‐Rong Yan & Qing‐Yu He. (2012) A novel andrographolide derivative AL ‐1 exerts its cytotoxicity on K 562 cells through a ROS ‐dependent mechanism . PROTEOMICS 13:1, pages 169-178.
Crossref
E. V. Kalinina, T. T. Berezov, A. A. Shtil’, N. N. Chernov, V. A. Glazunova, M. D. Novichkova & N. K. Nurmuradov. (2012) Expression of Peroxiredoxin 1, 2, 3, and 6 Genes in Cancer Cells during Drug Resistance Formation. Bulletin of Experimental Biology and Medicine 153:6, pages 879-882.
Crossref
Chien-Ju Lin, Chin-Cheng Lee, Yung-Luen Shih, Tsung-Yao Lin, Sheng-Hao Wang, Yuh-Feng Lin & Chwen-Ming Shih. (2012) Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. Free Radical Biology and Medicine 52:2, pages 377-391.
Crossref
Marilisa Sulpizio, Stefano Falone, Fernanda Amicarelli, Marco Marchisio, Fabrizio Di Giuseppe, Enrica Eleuterio, Carmine Di Ilio & Stefania Angelucci. (2011) Molecular basis underlying the biological effects elicited by extremely low-frequency magnetic field (ELF-MF) on neuroblastoma cells. Journal of Cellular Biochemistry 112:12, pages 3797-3806.
Crossref
Jeong Youp Park, Sun-A Kim, Joo Won Chung, Seungmin Bang, Seung Woo Park, Young-Ki Paik & Si Young Song. (2011) Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer. Journal of Cancer Research and Clinical Oncology 137:8, pages 1229-1238.
Crossref
Leslie B. Poole, Andrea Hall & Kimberly J. Nelson. 2001. Current Protocols in Toxicology. Current Protocols in Toxicology.
Juan D. Chavez, Michael R. Hoopmann, Chad R. Weisbrod, Kohji Takara & James E. Bruce. (2011) Quantitative Proteomic and Interaction Network Analysis of Cisplatin Resistance in HeLa Cells. PLoS ONE 6:5, pages e19892.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.